The Neuropathy Tracker—A mobile health application for ambulatory and self-administred assessment of neuropathy

Peripheral neuropathy is a common neurological disease and is a common complication of diabetes or cancer treatment. Early detection and treatment are crucial for improving the treatment of e.g., diabetic foot ulcers. However, neuropathy detection and monitoring requires examination of the motor and sensory systems and needs to be carried out in a clinical setting by trained professionals, leading to waiting time and delayed treatment. This paper presents the Neuropathy Tracker which is a Mobile Health (mHealth) tool for ambulatory self-assessment of neuropathy, which can be done by the patient at home. The app was designed in an iterative user-centered design (UCD) process involving neurologists, patients, and healthy subjects, thereby ensuring a high degree of clinical validity and usability. The assessment methodology in the app applies state-of-the-art neuropathy assessment methods and the app embodies a user-friendly and systematic assessment flow that guides the patient through the self-assessment. The Neuropathy Tracker tool was subject to a small feasibility study (N = 17), which showed a statistically significant (Pearson correlation ρ = 0.86, p < 0.05) but moderate (Concordance Correlation Coefficient (ρc) = 0.69) concurrent validity when compared with a standard clinical assessment method. All patients were able to complete the self-assessment without any help. As such, the technical and user experience design of the Neuropathy Tracker presents a stable mHealth tool that may be feasible for ambulatory self-assessment of neuropathy. Further clinical validation studies are, however, warranted before it is used in the clinical treatment of neuropathy.

Authors

Institutions

Publication Details

Journal
PLOS Digital Health
Published
2025-02-12
DOI
https://doi.org/10.1371/journal.pdig.0000725
Citations
3
Primary Topic
Botulinum Toxin and Related Neurological Disorders
Type
article
Field-Weighted Citation Impact
4.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Neuropathy Tracker—A mobile health application for ambulatory and self-administred assessment of neuropathy

Jakob E. Bardram, Martin Ballegaard, Mads Westermann, Julia G. Makulec
3 citations
PLOS Digital Health
Botulinum Toxin and Related Neurological Disorders
4.17
article

The Neuropathy Tracker—A mobile health application for ambulatory and self-administred assessment of neuropathy

Jakob E. Bardram, Martin Ballegaard, Mads Westermann, Julia G. Makulec
article en
3 citations

Abstract

Peripheral neuropathy is a common neurological disease and is a common complication of diabetes or cancer treatment. Early detection and treatment are crucial for improving the treatment of e.g., diabetic foot ulcers. However, neuropathy detection and monitoring requires examination of the motor and sensory systems and needs to be carried out in a clinical setting by trained professionals, leading to waiting time and delayed treatment. This paper presents the Neuropathy Tracker which is a Mobile Health (mHealth) tool for ambulatory self-assessment of neuropathy, which can be done by the patient at home. The app was designed in an iterative user-centered design (UCD) process involving neurologists, patients, and healthy subjects, thereby ensuring a high degree of clinical validity and usability. The assessment methodology in the app applies state-of-the-art neuropathy assessment methods and the app embodies a user-friendly and systematic assessment flow that guides the patient through the self-assessment. The Neuropathy Tracker tool was subject to a small feasibility study (N = 17), which showed a statistically significant (Pearson correlation ρ = 0.86, p < 0.05) but moderate (Concordance Correlation Coefficient (ρc) = 0.69) concurrent validity when compared with a standard clinical assessment method. All patients were able to complete the self-assessment without any help. As such, the technical and user experience design of the Neuropathy Tracker presents a stable mHealth tool that may be feasible for ambulatory self-assessment of neuropathy. Further clinical validation studies are, however, warranted before it is used in the clinical treatment of neuropathy.

PLOS Digital HealthVol. 4(2)
University of Copenhagen (DK), Zealand University Hospital (DK), Technical University of Denmark (DK)
Aarhus Universitet, Greater Copenhagen Health Science Partners, Copenhagen Center for Health Technology
Good health and well-being
Openalex Percentile: Top 7%
Botulinum Toxin and Related Neurological Disorders
4.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.